Scott M. Coiante - SVP, Chief Financial Officer at LEXICON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Financial Officer
Issuer Symbol
LXRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Scott M. Coiante since 24 Feb 2025

Holdings reported by Scott M. Coiante for LEXICON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 272,680 $322,076 $0.6700 12 Feb 2026 Direct Common Stock
Stock Option (Right to Buy) 409,020 12 Feb 2026 Direct Common Stock

Transactions reported by Scott M. Coiante for LEXICON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.